A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, with a personalized CRISPR gene-editing therapy. The treatment corrects an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results